Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00ACP
|
|||
| Former ID |
DIB014910
|
|||
| Drug Name |
Anti-HER-2 mab-FcgR2- FcgR4 fusion proteins
|
|||
| Synonyms |
Recombinant fusion proteins (cancer), Iterative therapeutics; Anti-HER2 mAb analogs (cancer),Iterative therapeutics; Anti-HER-2 mAb-FcgR2- FcgR4 fusion proteins (cancer); Anti-HER-2 mAb-FcgR2-FcgR4 fusion proteins (cancer), Iterative
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Iterative Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.